| Issue Date | Title | Author(s) |
| 2017-11 | A mutation in the viral sensor 2'-5'-oligoadenylate synthetase 2 causes failure of lactation. | Oakes, SR; Gallego-Ortega, D; Stanford, PM; Junankar, S; Au, WWY; Kikhtyak, Z; von Korff, A; Sergio, CM; Law, AMK; Castillo, LE; Allerdice, SL; Young, AIJ; Piggin, C; Whittle, B; Bertram, E; Naylor, MJ; Roden, DL; Donovan, J; Korennykh, A; Goodnow, CC; O'Bryan, MK; Ormandy, CJ |
| 2017-10-03 | A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts. | Nobis, M; Herrmann, D; Warren, SC; Kadir, S; Leung, W; Killen, M; Magenau, A; Stevenson, D; Lucas, MC; Reischmann, N; Vennin, C; Conway, JRW; Boulghourjian, A; Zaratzian, A; Law, AM; Gallego-Ortega, D; Ormandy, CJ; Walters, SN; Grey, ST; Bailey, J; Chtanova, T; Quinn, JMW; Baldock, PA; Croucher, PI; Schwarz, JP; Mrowinska, A; Zhang, L; Herzog, H; Masedunskas, A; Hardeman, EC; Gunning, PW; Del Monte-Nieto, G; Harvey, RP; Samuel, MS; Pajic, M; McGhee, EJ; Johnsson, A-KE; Sansom, OJ; Welch, HCE; Morton, JP; Strathdee, D; Anderson, KI; Timpson, P |
| 2022-05-03 | Activation of the viral sensor oligoadenylate synthetase 2 (Oas2) prevents pregnancy-driven mammary cancer metastases. | Ho, W-HJ; Law, AMK; Masle-Farquhar, E; Castillo, LE; Mawson, A; O'Bryan, MK; Goodnow, CC; Gallego-Ortega, D; Oakes, SR; Ormandy, CJ |
| 2022-07 | ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo. | Law, AMK; Chen, J; Colino-Sanguino, Y; Fuente, LRDL; Fang, G; Grimes, SM; Lu, H; Huang, RJ; Boyle, ST; Venhuizen, J; Castillo, L; Tavakoli, J; Skhinas, JN; Millar, EKA; Beretov, J; Rossello, FJ; Tipper, JL; Ormandy, CJ; Samuel, MS; Cox, TR; Martelotto, L; Jin, D; Valdes-Mora, F; Ji, HP; Gallego-Ortega, D |
| 2017-11-16 | Andy's Algorithms: new automated digital image analysis pipelines for FIJI. | Law, AMK; Yin, JXM; Castillo, L; Young, AIJ; Piggin, C; Rogers, S; Caldon, CE; Burgess, A; Millar, EKA; O'Toole, SA; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR |
| 2013-09 | BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer. | Stone, A; Cowley, MJ; Valdes-Mora, F; McCloy, RA; Sergio, CM; Gallego-Ortega, D; Caldon, CE; Ormandy, CJ; Biankin, AV; Gee, JMW; Nicholson, RI; Print, CG; Clark, SJ; Musgrove, EA |
| 2015-12 | ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells. | Gallego-Ortega, D; Ledger, A; Roden, DL; Law, AMK; Magenau, A; Kikhtyak, Z; Cho, C; Allerdice, SL; Lee, HJ; Valdes-Mora, F; Herrmann, D; Salomon, R; Young, AIJ; Lee, BY; Sergio, CM; Kaplan, W; Piggin, C; Conway, JRW; Rabinovich, B; Millar, EKA; Oakes, SR; Chtanova, T; Swarbrick, A; Naylor, MJ; O'Toole, S; Green, AR; Timpson, P; Gee, JMW; Ellis, IO; Clark, SJ; Ormandy, CJ |
| 2016-01-07 | ELF5 isoform expression is tissue-specific and significantly altered in cancer. | Piggin, CL; Roden, DL; Gallego-Ortega, D; Lee, HJ; Oakes, SR; Ormandy, CJ |
| 2020-01-02 | ELF5 modulates the estrogen receptor cistrome in breast cancer. | Piggin, CL; Roden, DL; Law, AMK; Molloy, MP; Krisp, C; Swarbrick, A; Naylor, MJ; Kalyuga, M; Kaplan, W; Oakes, SR; Gallego-Ortega, D; Clark, SJ; Carroll, JS; Bartonicek, N; Ormandy, CJ |
| 2013-11 | ELF5, normal mammary development and the heterogeneous phenotypes of breast cancer | Gallego-Ortega, D; Oakes, SR; Lee, HJ; Piggin, CL; Ormandy, CJ |
| 2013-05-23 | Functional characterization of cancer-associated Gab1 mutations. | Ortiz-Padilla, C; Gallego-Ortega, D; Browne, BC; Hochgräfe, F; Caldon, CE; Lyons, RJ; Croucher, DR; Rickwood, D; Ormandy, CJ; Brummer, T; Daly, RJ |
| 2016-01-05 | Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live Tissue. | Erami, Z; Herrmann, D; Warren, SC; Nobis, M; McGhee, EJ; Lucas, MC; Leung, W; Reischmann, N; Mrowinska, A; Schwarz, JP; Kadir, S; Conway, JRW; Vennin, C; Karim, SA; Campbell, AD; Gallego-Ortega, D; Magenau, A; Murphy, KJ; Ridgway, RA; Law, AM; Walters, SN; Grey, ST; Croucher, DR; Zhang, L; Herzog, H; Hardeman, EC; Gunning, PW; Ormandy, CJ; Evans, TRJ; Strathdee, D; Sansom, OJ; Morton, JP; Anderson, KI; Timpson, P |
| 2011-10 | Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. | Lee, HJ; Hinshelwood, RA; Bouras, T; Gallego-Ortega, D; Valdés-Mora, F; Blazek, K; Visvader, JE; Clark, SJ; Ormandy, CJ |
| 2007-01-25 | Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions | Oakes, SR; Robertson, FG; Kench, JG; Gardiner-Garden, M; Wand, MP; Green, JE; Ormandy, CJ |
| 2020-02 | MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma. | Castillo, L; Young, AIJ; Mawson, A; Schafranek, P; Steinmann, AM; Nessem, D; Parkin, A; Johns, A; Chou, A; Law, AMK; Lucas, MC; Murphy, KJ; Deng, N; Gallego-Ortega, D; Caldon, CE; Australian Pancreatic Cancer Genome Initiative (APGI); Timpson, P; Pajic, M; Ormandy, CJ; Oakes, SR |
| 2016-12-08 | MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib. | Young, AIJ; Law, AMK; Castillo, L; Chong, S; Cullen, HD; Koehler, M; Herzog, S; Brummer, T; Lee, EF; Fairlie, WD; Lucas, MC; Herrmann, D; Allam, A; Timpson, P; Watkins, DN; Millar, EKA; O'Toole, SA; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR |
| 2018 | Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion. | Young, AI; Timpson, P; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR |
| 2013-04 | Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. | Lee, HJ; Gallego-Ortega, D; Ledger, A; Schramek, D; Joshi, P; Szwarc, MM; Cho, C; Lydon, JP; Khokha, R; Penninger, JM; Ormandy, CJ |
| 2018 | Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology. | Valdes-Mora, F; Handler, K; Law, AMK; Salomon, R; Oakes, SR; Ormandy, CJ; Gallego-Ortega, D |
| 2021-04-13 | Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype. | Valdés-Mora, F; Salomon, R; Gloss, BS; Law, AMK; Venhuizen, J; Castillo, L; Murphy, KJ; Magenau, A; Papanicolaou, M; Rodriguez de la Fuente, L; Roden, DL; Colino-Sanguino, Y; Kikhtyak, Z; Farbehi, N; Conway, JRW; Sikta, N; Oakes, SR; Cox, TR; O'Donoghue, SI; Timpson, P; Ormandy, CJ; Gallego-Ortega, D |
